glp 1 medication reviews 2024 in Review: The Rise of GLP-1 Medications for Weight Loss The GLP-1 Agonists and Obesity:
Description
Below, we'll examine these findings more closely and discuss why this rebound effect occurs
View: 16812 Download: 278 Times Cited: 10
Without that integration, we risk: lifelong pharmacologic dependency weight regains after discontinuation affordability-driven inequity My final take: GLPs are a platform only if they are embedded inside structured metabolic care models, not standalone prescriptions
The American Journal of Clinical Nutrition , 344-367
Drug Type/Class 17.5.3
